The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome (Q44020766)

29 November 2017

The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome (English)

1 reference

polycystic ovary syndrome

29 November 2017

0 references

1 reference

1 reference

Dimitrios Panidis

1

1 reference

29 November 2017

Konstantinos Tziomalos

2

1 reference

29 November 2017

Efstathios Papadakis

3

1 reference

29 November 2017

Panagiotis Chatzis

4

1 reference

29 November 2017

Eleni A Kandaraki

5

1 reference

29 November 2017

Elena A Tsourdi

6

1 reference

29 November 2017

Ilias Katsikis

7

1 reference

29 November 2017

28 August 2013

1 reference

29 November 2017

Clinical Endocrinology

1 reference

29 November 2017

80

1 reference

29 November 2017

432-438

1 reference

29 November 2017

3

1 reference

Polycystic ovary syndrome: etiology, pathogenesis and diagnosis

29 November 2017

1 reference

The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis

21 January 2018

1 reference

Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society.

21 January 2018

1 reference

Lifestyle intervention and anti-obesity therapies in the polycystic ovary syndrome: impact on metabolism and fertility

21 January 2018

1 reference

XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients

21 January 2018

1 reference

Long term pharmacotherapy for obesity and overweight: updated meta-analysis.

21 January 2018

1 reference

Orlistat is as beneficial as metformin in the treatment of polycystic ovarian syndrome.

21 January 2018

1 reference

Effect of metformin, orlistat and pioglitazone treatment on mean insulin resistance and its biological variability in polycystic ovary syndrome.

21 January 2018

1 reference

An RCT of metformin versus orlistat for the management of obese anovulatory women

21 January 2018

1 reference

The effects of metformin or orlistat on obese women with polycystic ovary syndrome: a prospective randomized open-label study

21 January 2018

1 reference

Polycystic ovary syndrome is a risk factor for type 2 diabetes: results from a long-term prospective study

21 January 2018

1 reference

Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute spons

21 January 2018

1 reference

Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels

21 January 2018

1 reference

Diet, physical exercise and Orlistat administration increase serum anti-Müllerian hormone (AMH) levels in women with polycystic ovary syndrome (PCOS).

21 January 2018

1 reference

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

21 January 2018

1 reference

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

21 January 2018

1 reference

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans.

21 January 2018

1 reference

The effect of a hypocaloric diet with and without exercise training on body composition, cardiometabolic risk profile, and reproductive function in overweight and obese women with polycystic ovary syndrome.

21 January 2018

1 reference

Six weeks of structured exercise training and hypocaloric diet increases the probability of ovulation after clomiphene citrate in overweight and obese patients with polycystic ovary syndrome: a randomized controlled trial.

21 January 2018

1 reference

Role of diet in the treatment of polycystic ovary syndrome.

21 January 2018

1 reference

Exercise decreases plasma total homocysteine in overweight young women with polycystic ovary syndrome

21 January 2018

1 reference

Effects of acupuncture and exercise on insulin sensitivity, adipose tissue characteristics, and markers of coagulation and fibrinolysis in women with polycystic ovary syndrome: secondary analyses of a randomized controlled trial.

21 January 2018

1 reference

Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

21 January 2018

1 reference

Dyslipidemia induced by drugs used for the prevention and treatment of vascular diseases

21 January 2018

1 reference

Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society

21 January 2018

1 reference

Prominent role of low HDL-cholesterol in explaining the high prevalence of the metabolic syndrome in polycystic ovary syndrome

21 January 2018

1 reference

Low HDL predicts differential blood pressure effects from two weight-loss approaches: a secondary analysis of blood pressure from a randomized, clinical weight-loss trial

21 January 2018

1 reference

High-density lipoprotein metabolism and endothelial function

21 January 2018

1 reference

Anxiety is associated with hormonal and metabolic profile in women with polycystic ovarian syndrome.

21 January 2018

1 reference

Androgens and mood dysfunction in women: comparison of women with polycystic ovarian syndrome to healthy controls

21 January 2018

1 reference

Consensus on infertility treatment related to polycystic ovary syndrome

21 January 2018

1 reference

Orlistat accentuates the fat-induced fall in blood pressure in older adults

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/CEN.12305

1 reference

29 November 2017

1 reference